HLS Therapeutics Inc. (HLS) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Hls Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.229 -- 00:00:06.015 Good morning and welcome to the Q4 and Fiscal 2025 Financial Results Conference Call 00:00:06.015 -- 00:00:08.739 for HLS Therapeutics. 00:00:08.739 -- 00:00:11.222 At this time, all lines are in listen-only mode. 00:00:11.222 -- 00:00:15.047 Following the presentation, we will conduct a question and answer session. 00:00:15.047 -- 00:00:18.911 If at any time during this call you require immediate assistance, please press star zero 00:00:18.911 -- 00:00:22.957 for the operator. This call has been recorded on Thursday, March 12, 2026. 00:00:22.957 -- 00:00:28.103 At this time, I would like to turn the call over to David Mason, Investor Relations, 00:00:28.103 -- 00:00:31.081 for the introductory remarks. 00:00:31.081 -- 00:00:36.129 Thank you, Joelle. Good morning, everyone, and thanks for joining us today. 00:00:36.129 -- 00:00:41.358 With me on the call is Craig Millian, Chief Executive Officer, John Hanna, 00:00:41.358 -- 00:00:46.787 Chief Financial Officer, and Brian Walsh, Chief Commercial Officer. 00:00:46.787 -- 00:00:51.595 Earlier this morning, we issued a news release announcing the financial results for the 00:00:51.595 -- 00:00:56.240 three and 12 months ended December 31st, 2025. 00:00:56.528 -- 00:01:01.014 This news release, along with our MD&A and financial statements, is available on our 00:01:01.014 -- 00:01:04.439 website and on CDAR+. Please 00:01:04.439 -- 00:01:10.027 note that slides accompanying today's call can be viewed via the webcast, 00:01:10.027 -- 00:01:14.894 a link to which is available in our earnings release and on our website on the events 00:01:14.894 -- 00:01:16.617 page. 00:01:16.617 -- 00:01:21.003 Certain matters discussed in today's conference call or answers that may be given to 00:01:21.0...